Molecular and Cellular Biochemistry

, Volume 224, Issue 1–2, pp 53–67 | Cite as

The role of 3′-untranslated region (3′-UTR) mediated mRNA stability in cardiovascular pathophysiology

  • Christine M. Misquitta
  • Vimala R. Iyer
  • Eva S. Werstiuk
  • Ashok K. GroverEmail author


Knowledge of transcription and translation has advanced our understanding of cardiac diseases. Here, we present the hypothesis that the stability of mRNA mediated by the 3′-untranslated region (3′-UTR) plays a role in changing gene expression in cardiovascular pathophysiology. Several proteins that bind to sequences in the 3′-UTR of mRNA of cardiovascular targets have been identified. The affected mRNAs include those encoding β-adrenergic receptors, angiotensin II receptors, endothelial and inducible nitric oxide synthases, cyclooxygenase, endothelial growth factor, tissue necrosis factor (TNF-α), globin, elastin, proteins involved in cell cycle regulation, oncogenes, cytokines and lymphokines. We discuss: (a) the types of 3′-UTR sequences involved in mRNA stability, (b) AUF1, HuR and other proteins that bind to these sequences to either stabilize or destabilize the target mRNAs, and (c) the potential role of the 3′-UTR mediated mRNA stability in heart failure, myocardial infarction and hypertension. We hope that these concepts will aid in better understanding cardiovascular diseases and in developing new therapies.

myocardial infarction heart failure hypertension hypoxia adrenergic receptors nitric oxide synthase endothelium vascular RNA stability gene expression 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Abe R, Sakashita E, Yamamoto K, Sakamoto H: Two different RNA binding activities for the AU-rich element and the poly(A) sequence of the mouse neuronal protein mHuC. Nucleic Acids Res 24: 4895–4901, 1996Google Scholar
  2. 2.
    Aharon T, Schneider RJ: Selective destabilization of short-lived mRNAs with the granulocyte-macrophage colony-stimulating factor AU-rich 3′ noncoding region is mediated by a cotranslational mechanism. Mol Cell Biol 13: 1971–1980, 1993Google Scholar
  3. 3.
    Akamatsu W, Okano HJ, Osumi N, Inoue T, Nakamura S, Sakakibara S, Miura M, Matsuo N, Darnell RB, Okano H: Mammalian ELAV-like neuronal RNA-binding proteins HuB and HuC promote neuronal development in both the central and the peripheral nervous systems. Proc Natl Acad Sci USA 96: 9885–9890, 1999Google Scholar
  4. 4.
    Akashi M, Shaw G, Hachiya M, Elstner E, Suzuki G, Koeffler P: Number and location of AUUUA motifs: Role in regulating transiently expressed RNAs. Blood 83: 3182–3187, 1994Google Scholar
  5. 5.
    Alonso J, Sanchez DM, Monton M, Casado S, Lopez-Farre A: Endothelial cytosolic proteins bind to the 3′ untranslated region of endothelial nitric oxide synthase mRNA: Regulation by tumor necrosis factor alpha. Mol Cell Biol 17: 5719–5726, 1997Google Scholar
  6. 6.
    Arao Y, Kuriyama R, Kayama F, Kato S: A nuclear matrix-associated factor, SAF-B, interacts with specific isoforms of AUF1/hnRNP D. Arch Biochem Biophys 380: 228–236, 2000Google Scholar
  7. 7.
    Arnet UA, McMillan A, Dinerman JL, Ballermann B, Lowenstein CJ: Regulation of endothelial nitric-oxide synthase during hypoxia. J Biol Chem 271: 15069–15073, 1996Google Scholar
  8. 8.
    Bernstein PL, Herrick DJ, Prokipcak RD, Ross J: Control of c-myc mRNA half-life in vitro by a protein capable of binding to a coding region stability determinant. Genes Dev 6: 642–654, 1992Google Scholar
  9. 9.
    Blaxall BC, Pellett AC, Wu SC, Pende A, Port JD: Purification and characterization of beta-adrenergic receptor mRNA-binding proteins. J Biol Chem 275: 4290–4297, 2000Google Scholar
  10. 10.
    Bohjanen PR, Petryniak B, June CH, Thompson CB, Lindsten T: AU RNA-binding factors differ in their binding specificities and affinities. J Biol Chem 267: 6302–6309, 1992Google Scholar
  11. 11.
    Bohm M: Alterations of beta-adrenoceptor-G-protein-regulated adenylyl cyclase in heart failure. Mol Cell Biochem 147: 147–160, 1995Google Scholar
  12. 12.
    Bonnieu A, Roux P, Marty L, Jeanteur P, Piechaczyk M: AUUUA motifs are dispensable for rapid degradation of the mouse c-myc RNA. Oncogene 5: 1585–1588, 1990Google Scholar
  13. 13.
    Boudreau-Lariviere C, Chan RY, Wu J, Jasmin BJ: Molecular mechanisms underlying the activity-linked alterations in acetylcholinesterase mRNAs in developing vs. adult rat skeletal muscles. J Neurochem 74: 2250–2258, 2000Google Scholar
  14. 14.
    Brewer G: Characterization of c-myc 3′ to 5′ mRNA decay activities in an in vitro system. J Biol Chem 273: 34770–34774, 1998Google Scholar
  15. 15.
    Buzby JS, Brewer G, Nugent DJ: Developmental regulation of RNA transcript destabilization by A+U-rich elements is AUF1-dependent. J Biol Chem 274: 33973–33978, 1999Google Scholar
  16. 16.
    Buzby JS, Lee SM, Van Winkle P, DeMaria CT, Brewer G, Cairo MS: Increased granulocyte-macrophage colony-stimulating factor mRNA instability in cord vs. adult mononuclear cells is translation-dependent and associated with increased levels of A+U-rich element binding factor. Blood 88: 2889–2897, 1996Google Scholar
  17. 17.
    Cairns P, Okami K, King P, Bonacum J, Ahrendt S, Wu L, Mao L, Jen J, Sidransky D: Genomic organization and mutation analysis of Hel-N1 in lung cancers with chromosome 9p21 deletions. Cancer Res 57: 5356–5359, 1997Google Scholar
  18. 18.
    Caruccio N, Ross J: Purification of a human polyribosome-associated 3′ to 5′ exoribonuclease. J Biol Chem 269: 31814–31821, 1994Google Scholar
  19. 19.
    Castellano M, Bohm M: The cardiac beta-adrenoceptor-mediated signaling pathway and its alterations in hypertensive heart disease. Hypertension 29: 715–722, 1997Google Scholar
  20. 20.
    Chen CY, Chen TM, Shyu AB: Interplay of two functionally and structurally distinct domains of the c-fos AU-rich element specifies its mRNA-destabilizing function. Mol Cell Biol 14: 416–426, 1994Google Scholar
  21. 21.
    Chen CY, Shyu AB: Selective degradation of early-response-gene mRNAs: Functional analyses of sequence features of the AU-rich elements. Mol Cell Biol 14: 8471–8482, 1994Google Scholar
  22. 22.
    Chen CY, Xu N, Shyu AB: mRNA decay mediated by two distinct AU-rich elements from c-fos and granulocyte-macrophage colonystimulating factor transcripts: Different deadenylation kinetics and uncoupling from translation. Mol Cell Biol 15: 5777–5788, 1995Google Scholar
  23. 23.
    Chkheidze AN, Lyakhov DL, Makeyev AV, Morales J, Kong J, Liebhaber SA: Assembly of the alpha-globin mRNA stability complex reflects binary interaction between the pyrimidine-rich 3′ untranslated region determinant and poly(C) binding protein alphaCP. Mol Cell Biol 19: 4572–4581, 1999Google Scholar
  24. 24.
    Chou TC, Yen MH, Li CY, Ding YA: Alterations of nitric oxide synthase expression with aging and hypertension in rats. Hypertension 31: 643–648, 1998Google Scholar
  25. 25.
    Claffey KP, Shih SC, Mullen A, Dziennis S, Cusick JL, Abrams KR, Lee SW, Detmar M: Identification of a human VPF/VEGF 3′-untranslated region mediating hypoxia-induced mRNA stability. Mol Biol Cell 9: 469–481, 1998Google Scholar
  26. 26.
    Cohen SN, McDowall KJ: RNase E: Still a wonderfully mysterious enzyme. Mol Microbiol 23: 1099–1106, 1997Google Scholar
  27. 27.
    Copper G: Basic determinants of myocardial hypertrophy: A review of molecular mechanisms. Annu Rev Med 48: 13–23, 1997Google Scholar
  28. 28.
    Cory CR, McCutcheon LJ, O'Grady M, Pang AW, Geiger JD, O'Brien PJ: Compensatory downregulation of myocardial Ca channel in SR from dogs with heart failure. Am J Physiol 264: H926–H937, 1993Google Scholar
  29. 29.
    Curatola AM, Nadal MS, Schneider RJ: Rapid degradation of AU-rich element (ARE) mRNAs is activated by ribosome transit and blocked by secondary structure at any position 5′ to the ARE. Mol Cell Biol 15: 6331–6340, 1995Google Scholar
  30. 30.
    Danner S, Frank M, Lohse MJ: Agonist regulation of human beta2-adrenergic receptor mRNA stability occurs via a specific AU-rich element. J Biol Chem 273: 3223–3229, 1998Google Scholar
  31. 31.
    DeMaria CT, Brewer G: AUF1 binding affinity to A+U-rich elements correlates with rapid mRNA degradation. J Biol Chem 271: 12179–12184, 1996Google Scholar
  32. 32.
    DeMaria CT, Sun Y, Long L, Wagner BJ, Brewer G: Structural determinants in AUF1 required for high affinity binding to A+U-rich elements. J Biol Chem 272: 27635–27643, 1997Google Scholar
  33. 33.
    DeMaria CT, Sun Y, Wagner BJ, Long L, Brewer GA: Structural determination in AUF1 required for high affinity binding to A+U-rich elements. Nucleic Acids Symp Ser 12–14, 1997Google Scholar
  34. 34.
    Dixon DA, Kaplan CD, McIntyre TM, Zimmerman GA, Prescott SM: Post-transcriptional control of cyclooxygenase-2 gene expression. The role of the 3′-untranslated region. J Biol Chem 275: 11750–11757, 2000Google Scholar
  35. 35.
    Dominiczak AF, Bohr DF: Nitric oxide and its putative role in hypertension. Hypertension 25: 1202–1211, 1995Google Scholar
  36. 36.
    Doyle GA, Betz NA, Leeds PF, Fleisig AJ, Prokipcak RD, Ross J: The c-myc coding region determinant-binding protein: A member of a family of KH domain RNA-binding proteins. Nucleic Acids Res 26: 5036–5044, 1998Google Scholar
  37. 37.
    Ehrenman K, Long L, Wagner BJ, Brewer G: Characterization of cDNAs encoding the murine A+U-rich RNA-binding protein AUF1. Gene 149: 315–319, 1994Google Scholar
  38. 38.
    Fan XC, Steitz JA: HNS, a nuclear-cytoplasmic shuttling sequence in HuR. Proc Natl Acad Sci USA 95: 15293–15298, 1998Google Scholar
  39. 39.
    Fan XC, Steitz JA: Overexpression of HuR, a nuclear-cytoplasmic shuttling protein, increases the in vivo stability of ARE-containing mRNAs. EMBO J 17: 3448–3460, 1998Google Scholar
  40. 40.
    Forstermann U, Boissel JP, Kleinert H: Expressional control of the ‘constitutive’ isoforms of nitric oxide synthase (NOS I and NOS III). FASEB J 12: 773–790, 1998Google Scholar
  41. 41.
    Galea E, Feinstein DL: Regulation of the expression of the inflammatory nitric oxide synthase (NOS2) by cyclic AMP. FASEB J 13: 2125–2137, 1999Google Scholar
  42. 42.
    Gao FB, Carson CC, Levine T, Keene JD: Selection of a subset of mRNAs from combinatorial 3′ untranslated region libraries using neuronal RNA-binding protein Hel-N1. Proc Natl Acad Sci USA 91: 11207–11211, 1994Google Scholar
  43. 43.
    Goswami PC, Sheren J, Albee LD, Parsian A, Sim JE, Ridnour LA, Higashikubo R, Gius D, Hunt CR, Spitz DR: Cell cycle-coupled variation in topoisomerase IIalpha mRNA is regulated by the 3′-untranslated region: Possible role of redox-sensitive protein binding in mRNA accumulation. J Biol Chem 275: 38384–38392, 2000Google Scholar
  44. 44.
    Griendling KK, Ushio-Fukai M, Lassègue B, Alexander RW: Angiotensin II signaling in vascular smooth muscle - new concepts. Hypertension 29: 366–373, 1997Google Scholar
  45. 45.
    Hamilton BJ, Burns CM, Nichols RC, Rigby WFC: Modulation of AUUUA response element binding by heterogeneous nuclear ribonucleoprotein A1 in human T lymphocytes. The roles of cytoplasmic location, transcription, and phosphorylation. J Biol Chem 272: 28732–28741, 1997Google Scholar
  46. 46.
    Hattori Y, Gross SS: Cycloheximide induces nitric oxide synthase mRNA in vascular smooth muscle cells by prolonging mRNA lifetime. Biochem Mol Biol Int 37: 439–445, 1995Google Scholar
  47. 47.
    Haywood GA, Gullestad L, Katsuya T, Hutchinson HG, Pratt RE, Horiuchi M, Fowler MB: AT1 and AT2 angiotensin receptor gene expression in human heart failure. Circulation 95: 1201–1206, 1997Google Scholar
  48. 48.
    Henics T, Nagy E, Szekeres-Bartho J: Interaction of AU-rich sequence binding proteins with actin: Possible involvement of the actin cytoskeleton in lymphokine mRNA turnover. J Cell Physiol 173: 19–27, 1997Google Scholar
  49. 49.
    Henics T, Sanfridson A, Hamilton BJ, Nagy E, Rigby WF: Enhanced stability of interleukin-2 mRNA in MLA 144 cells. Possible role of cytoplasmic AU-rich sequence-binding proteins. J Biol Chem 269: 5377–5383, 1994Google Scholar
  50. 50.
    Herrick DJ, Ross J: The half-life of c-myc mRNA in growing and serum-stimulated cells: Influence of the coding and 3′ untranslated regions and role of ribosome translocation. Mol Cell Biol 14: 2119–2128, 1994Google Scholar
  51. 51.
    Hew Y, Lau C, Grzelczak Z, Keeley FW: Identification of a GA-rich sequence as a protein-binding site in the 3′-untranslated region of chicken elastin mRNA with a potential role in the developmental regulation of elastin mRNA stability. J Biol Chem 275: 24857–24864, 2000Google Scholar
  52. 52.
    Homcy CJ, Vatner SF, Vatner DE: Beta-adrenergic receptor regulation in the heart in pathophysiologic states: Abnormal adrenergic responsiveness in cardiac disease. Annu Rev Physiol 53: 137–159, 1991Google Scholar
  53. 53.
    Huang LY, Tholanikunnel BG, Vakalopoulou E, Malbon CC: The M(r) 35,000 beta-adrenergic receptor mRNA-binding protein induced by agonists requires both an AUUUA pentamer and U-rich domains for RNA recognition. J Biol Chem 268: 25769–25775, 1993Google Scholar
  54. 54.
    Huang PL, Huang Z, Mashimo H, Bloch KD, Moskowitz MA, Bevan JA, Fishman MC: Hypertension in mice lacking the gene for endothelial nitric oxide synthase (see comments). Nature 377: 239–242, 1995Google Scholar
  55. 55.
    Iwashina M, Hirata Y, Imai T, Sato K, Marumo F: Molecular cloning of endothelial, inducible nitric oxide synthase gene from rat aortic endothelial cell. Eur J Biochem 237: 668–673, 1996Google Scholar
  56. 56.
    Jarrousse AS, Petit F, Kreutzer-Schmid C, Gaedigk R, Schmid HP: Possible involvement of proteasomes (prosomes) in AUUUA-mediated mRNA decay. J Biol Chem 274: 5925–5930, 1999Google Scholar
  57. 57.
    Jiang X, Diwa A, Belasco JG: Regions of RNase E important for 5′-end-dependent RNA cleavage and autoregulated synthesis. J Bacteriol 182: 2468–2475, 2000Google Scholar
  58. 58.
    Kajita Y, Nakayama J, Aizawa M, Ishikawa F: The UUAG-specific RNA binding protein, heterogeneous nuclear ribonucleoprotein D0. Common modular structure and binding properties of the 2xRBDGly family. J Biol Chem 270: 22167–22175, 1995Google Scholar
  59. 59.
    Katz DA, Theodorakis NG, Cleveland DW, Lindsten T, Thompson CB: AU-A, an RNA-binding activity distinct from hnRNP A1, is selective for AUUUA repeats and shuttles between the nucleus and the cytoplasm. Nucleic Acids Res 22: 238–246, 1994Google Scholar
  60. 60.
    Kiledjian M, DeMaria CT, Brewer G, Novick K: Identification of AUF1 (heterogeneous nuclear ribonucleoprotein D) as a component of the alpha-globin mRNA stability complex (published erratum appears in Mol Cell Biol 17(10): 6202, 1997). Mol Cell Biol 17: 4870–4876, 1997Google Scholar
  61. 61.
    Kim YU, Rus HG, Fisher SN, Pitha PM, Shin ML: Binding of a protein to an AU-rich domain of tumour necrosis factor alpha mRNA as a 35 kDa complex and its regulation in primary rat astrocytes. Biochem J 316: 455–460, 1996Google Scholar
  62. 62.
    Klett. CPR, Printz MP, Bader M, Ganten D, Eggena P: Angiotensinogen messenger RNA stabilization by angiotensin II. J Hypertens 14: S25–S36, 1996Google Scholar
  63. 63.
    Laroia G, Cuesta R, Brewer G, Schneider RJ: Control of mRNA decay by heat shock-ubiquitin-proteasome pathway. Science 284: 499–502, 1999Google Scholar
  64. 64.
    Lasa M, Mahtani KR, Finch A, Brewer G, Saklatvala J, Clark AR: Regulation of cyclooxygenase 2 mRNA stability by the mitogen-activated protein kinase p38 signaling cascade. Mol Cell Biol 20: 4265–4274, 2000Google Scholar
  65. 65.
    Lee CH, Leeds P, Ross J: Purification and characterization of a polysomeassociated endoribonuclease that degrades c-myc mRNA in vitro. J Biol Chem 273: 25261–25271, 1998Google Scholar
  66. 66.
    Leeds P, Kren BT, Boylan JM, Betz NA, Steer CJ, Gruppuso PA, Ross J: Developmental regulation of CRD-BP, an RNA-binding protein that stabilizes c-myc mRNA in vitro. Oncogene 14: 1279–1286, 1997Google Scholar
  67. 67.
    Levy NS, Chung S, Furneaux H, Levy AP: Hypoxic stabilization of vascular endothelial growth factor mRNA by the RNA-binding protein HuR. J Biol Chem 273: 6417–6423, 1998Google Scholar
  68. 68.
    Loflin P, Chen CY, Shyu AB: Unraveling a cytoplasmic role for hnRNP D in the in vivo mRNA destabilization directed by the AU-rich element. Genes Dev 13: 1884–1897, 1999Google Scholar
  69. 69.
    Ma WJ, Furneaux H: Localization of the human HuR gene to chromosome 19p13.2. Hum Genet 99: 32–33, 1997Google Scholar
  70. 70.
    Mackie GA: Stabilization of circular rpsT mRNA demonstrates the 5′-end dependence of RNase E action in vivo. J Biol Chem 275: 25069–25072, 2000Google Scholar
  71. 71.
    Malter JS: Identification of an AUUUA-specific messenger RNA binding protein. Science 246: 664–666, 1989Google Scholar
  72. 72.
    Malter JS, Hong Y: A redox switch and phosphorylation are involved in the post-translational up-regulation of the adenosine-uridine binding factor by phorbol ester and ionophore. J Biol Chem 266: 3167–3171, 1991Google Scholar
  73. 73.
    Maurer F, Tierney M, Medcalf RL: An AU-rich sequence in the 3′-UTR of plasminogen activator inhibitor type 2 (PAI-2) mRNA promotes PAI-2 mRNA decay and provides a binding site for nuclear HuR. Nucleic Acids Res 27: 1664-1673, 1999Google Scholar
  74. 74.
    McQuillan LP, Leung GK, Marsden PA, Kostyk SK, Kourembanas S: Hypoxia inhibits expression of eNOS via transcriptional and posttranscriptional mechanisms (published errata appear in Am J Physiol 268: 1995, section H following table of contents and 268: section H following table of contents). Am J Physiol 267: H1921–H1927, 1994Google Scholar
  75. 75.
    Mijatovic T, Houzet L, Defrance P, Droogmans L, Huez G, Kruys V: Tumor necrosis factor-alpha mRNA remains unstable and hypoadenylated upon stimulation of macrophages by lipopolysaccharides. Eur J Biochem 267: 6004–6012, 2000Google Scholar
  76. 76.
    Mitchell P, Tollervey D: mRNA stability in eukaryotes. Curr Opin Genet Dev 10: 193–198, 2000Google Scholar
  77. 77.
    Miyamoto Y, Saito Y, Kajiyama N, Yoshimura M, Shimasaki Y, Nakayama M, Kamitani S, Harada M, Ishikawa M, Kuwahara K, Ogawa E, Hamanaka I, Takahashi N, Kaneshige T, Teraoka H, Akamizu T, Azuma N, Yoshimasa Y, Yoshimasa T, Itoh H, Masuda I, Yasue H, Nakao K: Endothelial nitric oxide synthase gene is positively associated with essential hypertension. Hypertension 32: 3–8, 1998Google Scholar
  78. 78.
    Muresu R, Baldini A, Gress T, Posner JB, Furneaux HM, Siniscalco M: Mapping of the gene coding for a paraneoplastic encephalomyelitis antigen (HuD) to human chromosome site 1p34. Cytogenet Cell Genet 65: 177–178, 1994Google Scholar
  79. 79.
    Nakamaki T, Imamura J, Brewer G, Tsuruoka N, Koeffler HP: Characterization of adenosine-uridine-rich RNA binding factors. J Cell Physiol 165: 484–492, 1995Google Scholar
  80. 80.
    Park S, Myszka DG, Yu M, Littler SJ, Laird-Offringa IA: HuD RNA recognition motifs play distinct roles in the formation of a stable complex with AU-rich RNA. Mol Cell Biol 20: 4765–4772, 2000Google Scholar
  81. 81.
    Pende A, Giacche M, Castigliola L, Contini L, Passerone G, Patrone M, Port JD, Lotti G: Characterization of the binding of the RNA-binding protein AUF1 to the human AT(1) receptor mRNA. Biochem Biophys Res Commun 266: 609–614, 1999Google Scholar
  82. 82.
    Pende A, Tremmel KD, DeMaria CT, Blaxall BC, Minobe WA, Sherman JA, Bisognano JD, Bristow MR, Brewer G, Port J: Regulation of the mRNA-binding protein AUF1 by activation of the beta-adrenergic receptor signal transduction pathway. J Biol Chem 271: 8493–8501, 1996Google Scholar
  83. 83.
    Peng SS, Chen CY, Shyu AB: Functional characterization of a non-AUUUA AU-rich element from the c-jun proto-oncogene mRNA: Evidence for a novel class of AU-rich elements. Mol Cell Biol 16: 1490–1499, 1996Google Scholar
  84. 84.
    Pinol-Roma S, Dreyfuss G: Shuttling of pre-mRNA binding proteins between nucleus and cytoplasm. Nature 355: 730–732, 1992Google Scholar
  85. 85.
    Ponka P: Cellular iron metabolism. Kidney Int 69(suppl): S2–S11, 1999Google Scholar
  86. 86.
    Ponka P, Beaumont C, Richardson DR: Function and regulation of transferrin and ferritin. Semin Hematol 35: 35–54, 1998Google Scholar
  87. 87.
    Ponka P, Lok CN: The transferrin receptor: Role in health and disease. Int J Biochem Cell Biol 31: 1111–1137, 1999Google Scholar
  88. 88.
    Port JD, Huang LY, Malbon CC: Beta-adrenergic agonists that downregulate receptor mRNA up-regulate a M(r) 35,000 protein(s) that selectively binds to beta-adrenergic receptor mRNAs. J Biol Chem 267: 24103–24108, 1992Google Scholar
  89. 89.
    Prokipcak RD, Herrick DJ, Ross J: Purification and properties of a protein that binds to the C-terminal coding region of human c-myc mRNA. J Biol Chem 269: 9261–9269, 1994Google Scholar
  90. 90.
    Qi M, Bassani JW, Bers DM, Samarel AM: Phorbol 12-myristate 13-acetate alters SR Ca(2+)-ATPase gene expression in cultured neonatal rat heart cells. Am J Physiol 271: H1031–H1039, 1996Google Scholar
  91. 91.
    Qi M, Shannon TR, Euler DE, Bers DM, Samarel AM: Downregulation of sarcoplasmic reticulum Ca(2+)-ATPase during progression of left ventricular hypertrophy. Am J Physiol 272: H2416–H2424, 1997Google Scholar
  92. 92.
    Rajagopalan LE, Malter JS: Modulation of granulocyte-macrophage colony-stimulating factor mRNA stability in vitro by the adenosineuridine binding factor. J Biol Chem 269: 23882–23888, 1994Google Scholar
  93. 93.
    Ristimaki A, Narko K, Hla T: Down-regulation of cytokine-induced cyclo-oxygenase-2 transcript isoforms by dexamethasone: Evidence for post-transcriptional regulation. Biochem J 318: 325–331, 1996Google Scholar
  94. 94.
    Roberts AB, Vodovotz Y, Roche NS, Sporn MB, Nathan CF: Role of nitric oxide in antagonistic effects of transforming growth factor-beta and interleukin-1 beta on the beating rate of cultured cardiac myocytes. Mol Endocrinol 6: 1921–1930, 1992Google Scholar
  95. 95.
    Rodriguez-Pascual F, Hausding M, Ihrig-Biedert I, Furneaux H, Levy AP, Forstermann U, Kleinert H: Complex contribution of the 3′-untranslated region to the expressional regulation of the human inducible nitric-oxide synthase gene. Involvement of the RNA-binding protein HuR. J Biol Chem 275: 26040–26049, 2000Google Scholar
  96. 96.
    Ross J: mRNA stability in mammalian cells. Microbiol Rev 59: 423–450, 1995Google Scholar
  97. 97.
    Ross J, Peltz SW, Kobs G, Brewer G: Histone mRNA degradation in vivo: The first detectable step occurs at or near the 3′ terminus. Mol Cell Biol 6: 4362–4371, 1986Google Scholar
  98. 98.
    Roy N, Laflamme G, Raymond V: 5′ untranslated sequences modulate rapid mRNA degradation mediated by 3′ AU-rich element in v-/c-fos recombinants. Nucleic Acids Res 20: 5753–5762, 1992Google Scholar
  99. 99.
    Sack N, Klly P: The energy substrate switch during development of heart failure: Gene regulatory mechanisms. Int J Mol Med 1: 17–24(review), 1998Google Scholar
  100. 100.
    Sanchez dM, Alonso J, Gonzalez-Fernandez F, de la OJ, Monton M, Rodriguez-Feo JA, Guerra JI, Arriero MM, Rico L, Casado S, Lopez-Farre A: Evidence that an endothelial cytosolic protein binds to the 3′-untranslated region of endothelial nitric oxide synthase mRNA. J Vasc Res 36: 201–208, 1999Google Scholar
  101. 101.
    Savant-Bhonsale S, Cleveland DW: Evidence for instability of mRNAs containing AUUUA motifs mediated through translation-dependent assembly of a > 20S degradation complex. Genes Dev 6: 1927–1939, 1992Google Scholar
  102. 102.
    Schulz R, Triggle CR: Role of NO in vascular smooth muscle and cardiac muscle function. Trends Pharmacol Sci 15: 255–259, 1994Google Scholar
  103. 103.
    Searles CD, Miwa Y, Harrison DG, Ramasamy S: Posttranscriptional regulation of endothelial nitric oxide synthase during cell growth (see comments). Circ Res 85: 588–595, 1999Google Scholar
  104. 104.
    Shen EC, Henry MF, Weiss VH, Valentini SR, Silver PA, Lee MS: Arginine methylation facilitates the nuclear export of hnRNP proteins. Genes Dev 12: 679–691, 1998Google Scholar
  105. 105.
    Theil EC: The IRE (iron regulatory element) family: Structures which regulate mRNA translation or stability. Biofactors 4: 87–93, 1993Google Scholar
  106. 106.
    Tholanikunnel BG, Granneman JG, Malbon CC: The M(r) 35,000 beta-adrenergic receptor mRNA-binding protein binds transcripts of G-protein-linked receptors which undergo agonist-induced destabilization. J Biol Chem 270: 12787–12793, 1995Google Scholar
  107. 107.
    Tholanikunnel BG, Malbon CC: A 20-nucleotide (A+U)-rich element of beta2-adrenergic receptor (beta2AR) mRNA mediates binding to beta2AR-binding protein and is obligate for agonist-induced destabilization of receptor mRNA. J Biol Chem 272: 11471–11478, 1997Google Scholar
  108. 108.
    Tholanikunnel BG, Raymond JR, Malbon CC: Analysis of the AUrich elements in the 3′-untranslated region of beta 2-adrenergic receptor mRNA by mutagenesis and identification of the homologous AU-rich region from different species. Biochemistry 38: 15564–15572, 1999Google Scholar
  109. 109.
    Unger T, Chung O, Csikos T, Culman J, Gallinat S, Gohlke P, Hohle S, Meffert S, Stoll M, Stroth U, Zhu YZ: Angiotensin receptors. J Hypertens 14(suppl): S95–S103, 1996Google Scholar
  110. 110.
    Vanhoutte PM: Endothelial dysfunction in hypertension. J Hypertens 14(suppl): S83–S93, 1996Google Scholar
  111. 111.
    Wagner BJ, DeMaria CT, Sun Y, Wilson GM, Brewer G: Structure and genomic organization of the human AUF1 gene: Alternative premRNA splicing generates four protein isoforms. Genomics 48: 195–202, 1998Google Scholar
  112. 112.
    Wagner BJ, Long L, Rao PN, Pettenati MJ, Brewer G: Localization and physical mapping of genes encoding the A+U-rich element RNAbinding protein AUF1 to human chromosomes 4 and X. Genomics 34: 219–222, 1996Google Scholar
  113. 113.
    Wang X, Kiledjian M, Weiss IM, Liebhaber SA: Detection and characterization of a 3′ untranslated region ribonucleoprotein complex associated with human alpha-globin mRNA stability (published erratum appears in Mol Cell Biol 15: 2331, 1995). Mol Cell Biol 15: 1769–1777, 1995Google Scholar
  114. 114.
    Wennborg A, Sohlberg B, Angerer D, Klein G, von Gabain A: A human RNase E-like activity that cleaves RNA sequences involved in mRNA stability control. Proc Natl Acad Sci USA 92: 7322–7326, 1995Google Scholar
  115. 115.
    Werstiuk ES, Lee RM: Vascular beta-adrenoceptor function in hypertension and in ageing (in process citation). Can J Physiol Pharmacol 78: 433–452, 2000Google Scholar
  116. 116.
    Wilson GM, Brewer G: Identification and characterization of proteins binding A+U-rich elements. Methods 17: 74–83, 1999Google Scholar
  117. 117.
    Wilson GM, Sun Y, Lu H, Brewer G: Assembly of AUF1 oligomers on U-rich RNA targets by sequential dimer association. J Biol Chem 274: 33374–33381, 1999Google Scholar
  118. 118.
    Wilson GM, Sun Y, Sellers J, Lu H, Penkar N, Dillard G, Brewer G: Regulation of AUF1 expression via conserved alternatively spliced elements in the 3′ untranslated region. Mol Cell Biol 19: 4056–4064, 1999Google Scholar
  119. 119.
    Xu K, Robida AM, Murphy TJ: Immediate-early MEK-1-dependent stabilization of rat smooth muscle cell cyclooxygenase-2 mRNA by Galpha(q)-coupled receptor signaling. J Biol Chem 275: 23012–23019, 2000Google Scholar
  120. 120.
    Xu N, Chen CY, Shyu AB: Modulation of the fate of cytoplasmic mRNA by AU-rich elements: Key sequence features controlling mRNA deadenylation and decay. Mol Cell Biol 17: 4611–4621, 1997Google Scholar
  121. 121.
    Zarain-Herzberg A, Afzal N, Elimban V, Dhalla NS: Decreased expression of cardiac sarcoplasmic reticulum Ca(2+)-pump ATPase in congestive heart failure due to myocardial infarction. Mol Cell Biochem 163-164: 285–290, 1996Google Scholar
  122. 122.
    Zhang W, Wagner BJ, Ehrenman K, Schaefer AW, DeMaria CT, Crater D, DeHaven K, Long L, Brewer G: Purification, characterization, and cDNA cloning of an AU-rich element RNA-binding protein, AUF1. Mol Cell Biol 13: 7652–7665, 1993Google Scholar
  123. 123.
    Zhao Z, Chang FC, Furneaux HM: The identification of an endonuclease that cleaves within an HuR binding site in mRNA. Nucleic Acids Res 28: 2695–2701, 2000Google Scholar
  124. 124.
    Zubiaga AM, Belasco JG, Greenberg ME: The nonamer UUAUUUAUU is the key AU-rich sequence motif that mediates mRNA degradation. Mol Cell Biol 15: 2219–2230, 1995Google Scholar

Copyright information

© Kluwer Academic Publishers 2001

Authors and Affiliations

  • Christine M. Misquitta
    • 1
  • Vimala R. Iyer
    • 2
  • Eva S. Werstiuk
    • 2
  • Ashok K. Grover
    • 2
    Email author
  1. 1.Department of BiologyMcMaster UniversityHamiltonCanada
  2. 2.Department of MedicineMcMaster UniversityHamiltonCanada

Personalised recommendations